Strensiq
RxNorm concept 1720264, brand name (bn).
- RxCUI
- 1720264
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1720264 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- asfotase alfa 40 MG/ML [Strensiq] (SBDC, ingredient of)
- asfotase alfa Injection [Strensiq] (SBDF, ingredient of)
- Strensiq Injectable Product (SBDG, ingredient of)
- 0.45 ML asfotase alfa 40 MG/ML Injection [Strensiq] (SBD, ingredient of)
- 0.7 ML asfotase alfa 40 MG/ML Injection [Strensiq] (SBD, ingredient of)
- 1 ML asfotase alfa 40 MG/ML Injection [Strensiq] (SBD, ingredient of)
- asfotase alfa 100 MG/ML [Strensiq] (SBDC, ingredient of)
- 0.8 ML asfotase alfa 100 MG/ML Injection [Strensiq] (SBD, ingredient of)
- asfotase alfa (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1720264 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1720264 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1720264. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.